PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michaela Tsai, MD
Piper Breast Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Maricopa Integrated Health System
Phoenix, Arizona, United States
- Providence Saint Joseph Medical Center
Burbank, California, United States
- Comprehensive Cancer Center
Palm Springs, California, United States
- Breastlink
Santa Ana, California, United States
- Redwood Regional Cancer Center
Santa Rosa, California, United States
- Exempla Saint Joseph Hospital
Denver, Colorado, United States
- Stamford Hospital
Stamford, Connecticut, United States
- the Breast Institute at Jfk Medical
Atlantis, Florida, United States
- Halifax Health Center for Oncology
Daytona Beach, Florida, United States
- Broward Health Medical Center
Fort Lauderdale, Florida, United States
- Regional Breast/21st Century Oncology
Fort Myers, Florida, United States
- Northeast Georgia Cancer Care
Athens, Georgia, United States
- Dekalb Medical Center
Decatur, Georgia, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Loyola University Medical Center
Chicago, Illinois, United States
- Alexian Brothers Medical Center
Elk Grove Village, Illinois, United States
- Delnor Community Hospital
Geneva, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Orchard Healthcare Research
Northbrook, Illinois, United States
- Cdh Cancer Center
Winfield, Illinois, United States
- Iu Health Bloomington
Bloomington, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Covenant Medical Center
Waterloo, Iowa, United States
- Harry & Jeanette Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, United States
- Medstar Harbor Hospital
Baltimore, Maryland, United States
- Mercy Medical Center
Baltimore, Maryland, United States
- Western Maryland Health System
Cumberland, Maryland, United States
- Lahey Clinic
Burlington, Massachusetts, United States
- Mount Auburn Hospital
Cambridge, Massachusetts, United States
- Metrowest Medical Center
Framingham, Massachusetts, United States
- St. Vincent Hospital
Worcester, Massachusetts, United States
- Detroit Clinical Research Center
Detroit, Michigan, United States
- Virginia Piper Cancer Institute
Minneapolis, Minnesota, United States
- St. Louis Cancer Care
Bridgeton, Missouri, United States
- Ssm Cancer Center
St Louis, Missouri, United States
- Roswell Park Cancer Center
Buffalo, New York, United States
- North Shore/monter Cancer Center
Lake Success, New York, United States
- Columbia University
New York, New York, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
- Tulsa Cancer Institute
Tulsa, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 31 Dec 2015
- Completion
- 31 Dec 2015
- Last update posted
- 29 Jan 2016
- Registered enrollment
- 820
- Registry id
- NCT01617954
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.